---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-062681"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2023-05-19T23:59:59+00:00"
generated_at: "2026-06-14T19:29:39.049518+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Collegium shareholders elect all nine directors, approve say-on-pay, ratify auditor

## Summary
- All nine director nominees re-elected; votes ranged from 25.9M to 28.3M for, with broker non-votes of ~2.46M.
- Advisory say-on-pay approved with 27,953,926 for, 315,383 against, 90,502 abstentions.
- Ratification of Deloitte & Touche as independent auditor for FY2023 passed with 30,742,534 for, 44,006 against, 29,155 abstentions.

## SEC filing metadata
- accession: 0001104659-23-062681
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2023-05-19T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/tm2316254d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-062681
- JSON: https://secwatch.observer/filing/0001104659-23-062681.json
- Plain text: https://secwatch.observer/filing/0001104659-23-062681.txt

## Key facts
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of nine Directors to hold office until the 2024 Annual Meeting of Shareholders.
  - Proposal: director election
  - Outcome: passed
  source text: Each of Rita Balice-Gordon, Garen Bohlin, Joseph Ciaffoni, John Fallon, John Freund, Michael Heffernan, Neil F. McFarlane, Gwen Melincoff, and Gino Santini was re-elected by the Company's shareholders as Directors to hold office until the 2024 Annual Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers.
  - Proposal: say on pay
  - Outcome: passed
  source text: On an advisory basis, the Company's shareholders approved the compensation of the Company's named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023.
  - Proposal: auditor ratification
  - Outcome: passed
  source text: Proposal 3 was approved by the Company's shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465923062681/0001104659-23-062681-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.